Filed: May 02, 2019 00:00
Coverage
-
August 12, 2020
The Patent Trial and Appeal Board has nixed the two claims left standing in a Sanofi-Aventis patent covering the Lantus SoloStar disposable insulin injection pen after finding back in April in a separate challenge that another claim in the patent was invalid.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS